The WHO issued an alert on Wednesday (October 5th) about cough and cold syrups produced by the Indian laboratory Maiden Pharmaceuticals which may have caused the death of 66 children in Gambia and have been distributed in other countries.
“
Laboratory analysis of samples
” of products confirms contamination by diethylene glycol and ethylene glycol in unacceptable quantities, indicates the WHO, which specifies that these products have been identified in Gambia but could have been distributed elsewhere in the world.